Your Messages Inbox
Your Article Summary
See Latest ArticlesCell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
Cell Therapeutics, 09/23/09
Cell Therapeutics, Inc. announced that it has been added to the NASDAQ OMX Global Biotechnology Index. Component changes to the index occurred prior to the market open on September 2009. The NASDAQ OMX Global Biotechnology Index is a modified market–capitalization weighted index designed to track the performance of the largest and most liquid companies engaged in the biotechnology sector.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Position statement of the Portuguese Society of Nephrology on the clinical use of biotechnological drugs in renal patients
Portuguese Journal of Nephrology and Hypertension, 10/12/09
Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09
Shire Reports Tolerability and Clinical Effects Results of DAYTRANA from Study in Adolescents with ADHD
Shire, 11/02/09
Article Search
Sponsor